oncologyconsultingnews.blogspot.com
Pharma Market StrategyNews and views from the world of pharmaceuticals and biotechnology
http://oncologyconsultingnews.blogspot.com/
News and views from the world of pharmaceuticals and biotechnology
http://oncologyconsultingnews.blogspot.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.5 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
58
SITE IP
172.217.10.129
LOAD TIME
0.516 sec
SCORE
6.2
Pharma Market Strategy | oncologyconsultingnews.blogspot.com Reviews
https://oncologyconsultingnews.blogspot.com
News and views from the world of pharmaceuticals and biotechnology
oncologyconsultingnews.blogspot.com
Pharma Market Strategy: July 2008
http://oncologyconsultingnews.blogspot.com/2008_07_01_archive.html
News and views from the world of pharmaceuticals and biotechnology. Tuesday, July 29, 2008. The recent news that Roche. Are looking to purchase the remaining shares in Genentech. Has certainly caused a a big stir in the Pharma industry. One of the main reasons the partnership blossomed was because Roche left Genentech largely alone and they had very clear marketing distinctions with Genentech responsible for the US and Roche handling the rest of the world. Time will tell on both fronts. The company's sci...
Pharma Market Strategy: June 2008
http://oncologyconsultingnews.blogspot.com/2008_06_01_archive.html
News and views from the world of pharmaceuticals and biotechnology. Tuesday, June 24, 2008. New clue to Alzheimer's found in brain protein. It has been known for a while that the brains of people with the memory-robbing form of dementia are cluttered with a plaque made up of beta-amyloid. A sticky protein that accumulates in the neurons of the brain. The big question, however, was whether this is a significant cause of the disease or a side effect. If the results are confirmed in humans, they this discov...
Pharma Market Strategy: The Pharma industry gets off to a slow start this week
http://oncologyconsultingnews.blogspot.com/2008/09/pharma-industry-gets-off-to-slow-start.html
News and views from the world of pharmaceuticals and biotechnology. Monday, September 22, 2008. The Pharma industry gets off to a slow start this week. Reports that the WHO may remove Sandoz. Authorization to sell some of it's antibiotics after discovering manufacturing problems at the plant. Notes that Indian officals may complain to the FDA regarding the ongoing issues with drugs from Ranbaxy. Still on the generics front, sanofi-aventis. Has improved its bid for Zentiva. Nestle yesterday said the amoun...
Pharma Market Strategy: May 2008
http://oncologyconsultingnews.blogspot.com/2008_05_01_archive.html
News and views from the world of pharmaceuticals and biotechnology. Wednesday, May 28, 2008. Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) and Takeda Pharmaceutical Company Limited recently announced. So what exactly is RNAi? Takeda becomes Alnylam’s strategic partner for RNAi therapeutics over a five-year period and the only Asian company to obtain a right of first negotiation to develop and commercialize Alnylam RN...
Pharma Market Strategy: Resumption after an extended hiatus
http://oncologyconsultingnews.blogspot.com/2009/08/resumption-after-extended-hiatus.html
News and views from the world of pharmaceuticals and biotechnology. Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Normal service will resume shortly. Subscribe to: Post Comments (Atom). View my complete profile. Follow me on Twitter! Subscribe Now: Feed Icon. The IN VIVO Blog.
TOTAL PAGES IN THIS WEBSITE
14
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: May 2008
http://hematologymarketinsights.blogspot.com/2008_05_01_archive.html
Monday, May 12, 2008. Knocking out cancer cells in Leukemia. Cancer initiating cells (CICs) or leukemia initiating cells (LICs) are stealth populations impervious to conventional chemotherapy and resistant to targeted cancer therapies. When a leukemia patient relapses following a period of remission, it is the LICs that are the cause of the disease’s re-emergence. Researchers at the Beth Israel Deaconess Medical Center. Their findings, which appear in Nature. The concept is a very simple one; 90% of exis...
oncologymarkettrends.blogspot.com
Oncology Market Trends: Cancer Research Blog Carnival #14 — Sciencebase Science Blog
http://oncologymarkettrends.blogspot.com/2008/10/cancer-research-blog-carnival-14.html
What's new in the world of cancer. Monday, October 6, 2008. Cancer Research Blog Carnival #14 — Sciencebase Science Blog. Well, this morning I had a nice surprise after finding that some posts in my science and cancer blog made the Cancer Research Blog Carnival. This weekend, thanks to the host David Bradley and ScienceBase. You can read more about this great Carnival concept on his blog. About the online event. Related articles by Zemanta. Cancer Research Blog Carnival. Cancer Research Blog Carnival.
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: September 2008
http://hematologymarketinsights.blogspot.com/2008_09_01_archive.html
Thursday, September 11, 2008. To all those who lost their lives on 9/11, there will be no blog posts today. We will remember them. Subscribe to: Posts (Atom). Pharmaceuticals, biotechnology, marketing strategy, cancer, oncology, competitive intelligence, landscape opportunity assessments, portfolio analysis. View my complete profile. Icarus Consultants, Inc. Follow Me on Twitter! Subscribe Now: Feed Icon. Subscribe in a reader. Enter your email address:. Ban academics from talking to ministers?
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Forgotten side of the Iraq war: shortage of meds for cancer patients
http://hematologymarketinsights.blogspot.com/2008/07/forgotten-side-of-iraq-war-shortage-of.html
Friday, July 25, 2008. Forgotten side of the Iraq war: shortage of meds for cancer patients. This interesting (and sad) letter in the New England Journal of Medicine. Highlights the shortage of chemotherapy treatments for children suffering from leukemia:. There was a significant inverse relationship between the amount of prescribed chemotherapy that was administered and the risk of relapse.". Subscribe to: Post Comments (Atom). View my complete profile. Icarus Consultants, Inc. Follow Me on Twitter!
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Precise location of an oncogene may determine the onset of childhood leukemia
http://hematologymarketinsights.blogspot.com/2008/07/precise-location-of-oncogene-may.html
Monday, July 14, 2008. Precise location of an oncogene may determine the onset of childhood leukemia. With intensive treatment involving chemotherapy, over half of children are cured. But scientists hope to be able to develop targeted therapies that are less toxic than chemotherapy, based on knowledge of the biological processes behind T-ALL. VIB-KU.Leuven) indicates that the location in the cell where these proteins are found plays an important role in the entire carcinogenic mechanism. Many forms of ca...
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Stand Up to Cancer!
http://hematologymarketinsights.blogspot.com/2008/07/stand-up-to-cancer.html
Wednesday, July 2, 2008. Stand Up to Cancer! Stand Up To Cancer, a new initiative to raise philanthropic dollars for accelerating ground-breaking research, launched recently through a large collaboration uniting the major television networks, entertainment industry executives, celebrities and prominent leaders in cancer research and patient advocacy. In addition to the nationally televised network fundraising event, other key elements of the initiative include:. The Stand: An interactive Facebook applica...
hematologymarketinsights.blogspot.com
Hematology Competitive Insights: Cancer: tracking progress for the treatment of CML
http://hematologymarketinsights.blogspot.com/2008/07/cancer-tracking-progress-for-treatment.html
Sunday, July 20, 2008. Cancer: tracking progress for the treatment of CML. This fascinating short video interviews some of the top leukemia doctors around the world and looks at how tracking faulty chromosomes is now routine for people with chronic myeloid leukemia. Experts such as Dr Brian Druker and Prof. John Goldman explain what sophisticated laboratory tests can tell about treatment success:. Haematology Lectures and Ebooks. Good blog.valuable,precious information.keep updating. Follow Me on Twitter!
oncologymarkettrends.blogspot.com
Oncology Market Trends: Eeek, I've been tagged! Now what?
http://oncologymarkettrends.blogspot.com/2008/09/eeek-ive-been-tagged-now-what.html
What's new in the world of cancer. Tuesday, September 2, 2008. Eeek, I've been tagged! I got tagged by my friend Sarah Arrow this morning. She's a lovely Essex lass who is the salt of the earth and would do anything for her friends. You can find her on Twitter. Or her excellent courier blog. Being tagged is a game bloggers play where they have to write six random things about their self, and tag six other people. It's a great way to spread the word about other people's blogs. 3 Curry is my favourite food.
cancertechinsights.blogspot.com
Cancer Technology and Insights: As a mark of respect
http://cancertechinsights.blogspot.com/2008/09/as-mark-of-respect.html
Cancer Technology and Insights. Latest developments in Oncology market trends and intelligence. Thursday, September 11, 2008. As a mark of respect. There will be no blog posts today in memory of those who died on 9/11 seven years ago. Blogging will resume tomorrow. Subscribe to: Post Comments (Atom). Pharmaceuticals, biotechnology, marketing strategy, cancer, oncology, competitive intelligence, landscape opportunity assessments, portfolio analysis. View my complete profile. Follow me on Twitter!
oncologymarkettrends.blogspot.com
Oncology Market Trends: September 2008
http://oncologymarkettrends.blogspot.com/2008_09_01_archive.html
What's new in the world of cancer. Sunday, September 21, 2008. Picture of the Day. From Trazy's Flickr Photostream - you can see it here. He does some awesome macro shots of various biology related subjects. This one is a "monster" culture cell - a huge mutant with two nuclei and one centrosome. A normal cell can be seen at the lower right. Posted by Sally Church. Thursday, September 11, 2008. Like many who lost friends and acquaintances on 9/11 seven years ago, today will be spent in quiet reflection.
TOTAL LINKS TO THIS WEBSITE
58
oncologyconsult.org
Oncology Consulting & Cancer Consulting - Oncology Resource Consultants
ORC offers a comprehensive array of services to hospitals, physicians, pharmaceutical companies, law firms, and the biotechnology community. 104 South Washington Street Rockville, MD 20850 P (301) 424-6000 F (301) 424-6005.
Oncology Consultants | Houston, TX | Overcoming Cancer
Media & Events. Introduction to Cancer Treatment. A Word about Clinical Trials. Getting a Second Opinion. Head and Neck Cancer. What Are Clinical Trials? Phases of Clinical Trials. How Are Clinical Trials Conducted? Participating in Clinical Trials. The Cost of Clinical Trials. Finding Specific Clinical Trials. The Future of Clinical Trials. Side Effects of Treatment. Diagnostic and Monitoring Tests. Lung Cancer - Non-Small Cell. Lung Cancer - Small Cell. Head and Neck Cancer. Birth Control and Sexuality.
oncologyconsultantsbahamas.com
Oncology Consultants Bahamas
Providing World Class Cancer Care to the Caribbean". Our Mission and Goals. Dr DuVaughn E. Curling. Dr Andre R. Clarke. Dr Theodore Turnquest received his Doctor of Medicine degree from the University of South Florida in 1995. He completed his Internal Medicine residency at Baylor College of Medicine in Houston, Texas. Dr DuVaughn E. Curling. Designed by X-tine Media.
oncologyconsultingintel.blogspot.com
Cancer Competitive Intelligence
New oncology developments in the world of pharmaceuticals and biotechnology. Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Normal service will resume shortly. Links to this post. Saturday, October 18, 2008. Increasing importance of competitive intelligence in bear markets.
oncologyconsultingnews.blogspot.com
Pharma Market Strategy
News and views from the world of pharmaceuticals and biotechnology. Monday, August 24, 2009. Resumption after an extended hiatus. Things have been really insanely busy on the work front over the last year, necessitating some radical prioritisation and thus I have only posted on Pharma Strategy Blog. Instead of here and Oncology Market Trends. Normal service will resume shortly. Monday, October 13, 2008. When tomorrow never comes. the rising cost of health care. The National Coalition on Health Care.
Oncology Convergence, Inc. (OCI)
Skip to main content. Call us : 1-877-754-7799. OCI combines clinical and financial experience to assist and guide oncology practices to maximize profits without sacrificing patient care, time or compliance. We help you work smarter. The OCI team focuses on oncology reimbursement, management, and technology. Oncology Convergence, Inc. (OCI) has one of the most specialized teams in the industry. December 27, 2016. By Jim Musslewhite, President, Oncology Convergence, []. Bad Debt, the Profit Killer.
Oncology, Corpus Christi Texas, Dr. Lalitha Janaki
Helping our patients to achieve the highest levels of wellness. Recognizing the need for professional, caring cancer treatment closer to patient’s homes, Dr. Ayman Ghraowi and Dr. Lalitha Janaki established the Christus Spohn Cancer Center Calallen network of clinics in 1996. Christus Spohn Cancer Center Calallen is the only cancer specialty group with offices in Corpus Christi, Aransas Pass, Alice, Beeville, Calallen, Kingsville and Rockport. Cancer and blood disorder consultation. Bull; TMA Delegate.
Oncology Case of the Week (COW)
Oncology Case of the Week (COW). Beings medicine: Chinese medicine to first-class brand enterprise forward - beings medicine - pharmaceutical industries. December 11, 2009, and the people listed on medicine in the Shenzhen Stock Exchange, becoming the sixth listed companies in Dongguan, Dongguan, achieved nearly 11 years IPO breakthrough. Britain is expected to Traditional Chinese Medicine Act enacted in 2011 - Medicine, United Kingdom - Pharmaceutical Industry. Look no further than the Southwest College...
Oncology Education
Sunday, 27 May 2012. Getting Better: 200 Years of Medicine. Well, this web space is becoming another area to share more and more videos from other sources.As a CPD space, that is OK in a way,if those videos are from legitimate sources, but not having any original content is not very good for a web space dealing with professional development . From next month onwards, we are trying to publish a column on Oncology research- A synopses of all the main oncology journals and original articles that month.
oncologycro.com
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
